Auranofin for Giardia Protozoa

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 6, 2016

Primary Completion Date

March 10, 2021

Study Completion Date

March 10, 2021

Conditions

Amoebic DysenteryGiardiasis

Interventions

DRUG

Auranofin

Auranofin is a gold-containing chemical salt available as 3mg capsules

OTHER

Placebo

Trial Locations (2)

International Center for Diarrheal Disease Research Bangladesh - Parasitology, Dhaka

Rajshahi Medical College Hospital, Rajshahi

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02736968 - Auranofin for Giardia Protozoa | Biotech Hunter | Biotech Hunter